Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

Locking in profits while you have them can help avoid downturns.

While several major biotech companies are laying off employees by the hundreds, one is dropping billions in acquisitions.

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax ...

The 552 million pounds ($747 million) raised by British biotechs in the first quarter of the year has been hailed as a “sign ...

Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first ...

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...

National competition, in collaboration with adMare BioInnovations, demonstrates AbbVie's commitment to a thriving biotech ecosystem in ...